Principal Financial Group
RLAY icon

Principal Financial Group’s Relay Therapeutics RLAY Stock Holding History

Principal Financial Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Buy
+10,458
New +$152K ﹤0.01% 2091
2024
Q3 		– Sell
-14,580
Closed -$95.1K – 2379
2024
Q2 		$95.1K Sell
14,580
-11,195
-43% -$76.5K ﹤0.01% 2224
2024
Q1 		$214K Sell
25,775
-1,880
-7% -$18.3K ﹤0.01% 2162
2023
Q4 		$304K Sell
27,655
-2,809
-9% -$23.7K ﹤0.01% 2060
2023
Q3 		$256K Buy
30,464
+4,507
+17% +$48.5K ﹤0.01% 2099
2023
Q2 		$326K Sell
25,957
-751
-3% -$9.34K ﹤0.01% 2051
2023
Q1 		$440K Buy
26,708
+3,020
+13% +$54.2K ﹤0.01% 1996
2022
Q4 		$354K Buy
23,688
+3,040
+15% +$58.2K ﹤0.01% 2062
2022
Q3 		$462K Buy
20,648
+3,899
+23% +$85.6K ﹤0.01% 1979
2022
Q2 		$280K Sell
16,749
-5,723
-25% -$123K ﹤0.01% 2203
2022
Q1 		$673K Buy
22,472
+72
+0.3% +$1.75K ﹤0.01% 2057
2021
Q4 		$688K Sell
22,400
-7,776
-26% -$246K ﹤0.01% 2055
2021
Q3 		$952K Buy
30,176
+326
+1% +$11K ﹤0.01% 2016
2021
Q2 		$1.09M Buy
29,850
+21,147
+243% +$697K ﹤0.01% 2019
2021
Q1 		$301K Buy
8,703
+1,852
+27% +$80.4K ﹤0.01% 2275
2020
Q4 		$285K Buy
+6,851
New +$310K ﹤0.01% 2247

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Principal Financial Group's RLAY Position: Q2 2026 in Review

Principal Financial Group opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 10,458 shares worth $196K. The stake represents ﹤0.01% of the portfolio and ranks #2091 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in RLAY as recently as Q2 2024.

Principal Financial Group first reported a position in RLAY in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.09M in Q2 2021. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Principal Financial Group held 10,458 shares of Relay Therapeutics worth $196K as of Q2 2026.
  • Relay Therapeutics was a new Principal Financial Group position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2091 holding.
  • Principal Financial Group first reported a position in Relay Therapeutics in Q4 2020 and has held it in 16 quarters since.
  • Principal Financial Group's Relay Therapeutics position peaked at $1.09M in Q2 2021.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.